Tomasz Huzarski

22.3k total citations
165 papers, 4.7k citations indexed

About

Tomasz Huzarski is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Tomasz Huzarski has authored 165 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Genetics, 49 papers in Oncology and 45 papers in Molecular Biology. Recurrent topics in Tomasz Huzarski's work include BRCA gene mutations in cancer (116 papers), Genetic factors in colorectal cancer (33 papers) and Ovarian cancer diagnosis and treatment (33 papers). Tomasz Huzarski is often cited by papers focused on BRCA gene mutations in cancer (116 papers), Genetic factors in colorectal cancer (33 papers) and Ovarian cancer diagnosis and treatment (33 papers). Tomasz Huzarski collaborates with scholars based in Poland, Canada and Australia. Tomasz Huzarski's co-authors include Jan Lubiński, Jacek Gronwald, Tomasz Byrski, Steven A. Narod, Cezary Cybulski, Anna Jakubowska, Bohdan Górski, Tadeusz Dębniak, Rebecca Dent and Dominika Wokołorczyk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tomasz Huzarski

160 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Huzarski Poland 35 2.4k 1.9k 1.8k 1.4k 860 165 4.7k
Cezary Cybulski Poland 34 2.0k 0.8× 1.5k 0.8× 1.9k 1.0× 1.4k 1.0× 986 1.1× 182 4.6k
Jacek Gronwald Poland 35 3.0k 1.3× 1.7k 0.9× 1.9k 1.1× 1.7k 1.2× 959 1.1× 183 5.3k
Tomasz Byrski Poland 31 1.9k 0.8× 1.3k 0.7× 1.5k 0.8× 1.2k 0.8× 704 0.8× 101 3.3k
Jórunn E. Eyfjörd Iceland 30 1.7k 0.7× 1.4k 0.7× 2.0k 1.1× 1.3k 0.9× 600 0.7× 64 3.8k
Kathleen M. Darcy United States 39 446 0.2× 1.8k 1.0× 2.1k 1.2× 961 0.7× 677 0.8× 174 5.1k
Mark L. Graham United States 26 1.1k 0.5× 2.2k 1.2× 1.3k 0.7× 1.7k 1.2× 741 0.9× 53 4.5k
A. Rubagotti Italy 32 1.3k 0.6× 1.6k 0.8× 638 0.4× 1.2k 0.9× 479 0.6× 131 3.7k
Masashi Takano Japan 38 415 0.2× 1.2k 0.6× 1.8k 1.0× 575 0.4× 936 1.1× 255 5.5k
R.I. Nicholson United Kingdom 25 1.0k 0.4× 1.1k 0.6× 884 0.5× 582 0.4× 240 0.3× 63 2.3k
R A McClelland United Kingdom 30 1.1k 0.4× 1.3k 0.7× 982 0.5× 505 0.4× 364 0.4× 45 2.5k

Countries citing papers authored by Tomasz Huzarski

Since Specialization
Citations

This map shows the geographic impact of Tomasz Huzarski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Huzarski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Huzarski more than expected).

Fields of papers citing papers by Tomasz Huzarski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Huzarski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Huzarski. The network helps show where Tomasz Huzarski may publish in the future.

Co-authorship network of co-authors of Tomasz Huzarski

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Huzarski. A scholar is included among the top collaborators of Tomasz Huzarski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Huzarski. Tomasz Huzarski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Machaj, Filip, Dominik Strapagiel, Marta Sobalska‐Kwapis, et al.. (2023). Analytical sensitivity of a method is critical in detection of low-level BRCA1 constitutional epimutation. Scientific Reports. 13(1). 16102–16102. 2 indexed citations
2.
Lubiński, Jan, Marcin Lener, Wojciech Marciniak, et al.. (2023). Serum Essential Elements and Survival after Cancer Diagnosis. Nutrients. 15(11). 2611–2611. 22 indexed citations
3.
Kozłowski, Mateusz, et al.. (2022). An Unusual Case of Vulvar Involvement in the Course of Granulomatosis with Polyangiitis. International Journal of Environmental Research and Public Health. 19(21). 13862–13862.
4.
Huzarski, Tomasz, et al.. (2022). Impact of Inertial Training on Muscle Strength and Quality of Life in Breast Cancer Survivors. International Journal of Environmental Research and Public Health. 19(6). 3278–3278. 7 indexed citations
5.
Friedländer, Michael, Val Gebski, Andrew R. Clamp, et al.. (2022). The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer. Annals of Oncology. 33(6). 593–601. 16 indexed citations
6.
Friedländer, Michael, Sarah J. Lord, Rebecca Asher, et al.. (2021). Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy. European Journal of Cancer. 154. 190–200. 9 indexed citations
7.
Kim, Shana J., Jan Lubiński, Tomasz Huzarski, et al.. (2021). Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 30(11). 2038–2043. 7 indexed citations
8.
Kluźniak, Wojciech, Dominika Wokołorczyk, Aniruddh Kashyap, et al.. (2019). Allelic modification of breast cancer risk in women with an NBN mutation. Breast Cancer Research and Treatment. 178(2). 427–431. 8 indexed citations
9.
Penson, Richard T., JA Ledermann, Christopher Brown, et al.. (2017). Efficacy of olaparib maintenance therapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by lines of prior chemotherapy: Phase III SOLO2 trial (ENGOT Ov-21). Annals of Oncology. 28. v331–v331. 4 indexed citations
10.
Byrski, Tomasz, Tomasz Huzarski, R. Dent, et al.. (2014). Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Research and Treatment. 147(2). 401–405. 177 indexed citations
11.
Huzarski, Tomasz, Cezary Cybulski, Dominika Wokołorczyk, et al.. (2014). Survival from breast cancer in patients with CHEK2 mutations. Breast Cancer Research and Treatment. 144(2). 397–403. 11 indexed citations
12.
Byrski, Tomasz, Jacek Gronwald, Tomasz Huzarski, et al.. (2012). Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment. Hereditary Cancer in Clinical Practice. 10(Suppl 3). A3–A3. 4 indexed citations
13.
Lubiński, Jan, Katarzyna Jaworska, Katarzyna Durda, et al.. (2011). Selenium and the risk of cancer in BRCA1 carriers. Hereditary Cancer in Clinical Practice. 9(Suppl 2). A5–A5. 10 indexed citations
14.
Gronwald, Jacek, Tomasz Byrski, Tomasz Huzarski, et al.. (2010). Genetyka kliniczna raka piersi i jajnika. Postępy Nauk Medycznych.
15.
Domagała, Paweł, Tomasz Huzarski, Jan Lubiński, K Gugała, & W Domagała. (2010). Immunophenotypic predictive profiling of BRCA1-associated breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(1). 55–64. 23 indexed citations
16.
Gronwald, Jacek, Cezary Cybulski, Janina Suchy, et al.. (2009). Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband. British Journal of Cancer. 100(9). 1508–1512. 25 indexed citations
17.
Cybulski, Cezary, Dominika Wokołorczyk, Tomasz Huzarski, et al.. (2006). A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Research and Treatment. 102(1). 119–122. 83 indexed citations
18.
Jakubowska, Anna, Jacek Gronwald, Janusz Menkiszak, et al.. (2006). Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Research and Treatment. 104(3). 299–308. 40 indexed citations
19.
Falkowski, Aleksander, et al.. (2004). Colour Doppler ultrasound in preoperative assessment of the neck vessels in patients with tumours of the oral cavity and the neck region.. PubMed. 10 Suppl 3. 63–6. 4 indexed citations
20.
Grabowski, Monika, Tomasz Huzarski, Jan Lubiński, & Andrzej Sikorski. (2002). Survival in patients with rare subtypes of renal cell carcinoma. British Journal of Urology. 89(6). 599–600. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cezary Cybulski Breakdown of academic impact, for papers by Jacek Gronwald Breakdown of academic impact, for papers by Tomasz Byrski Breakdown of academic impact, for papers by Jórunn E. Eyfjörd Breakdown of academic impact, for papers by Kathleen M. Darcy Breakdown of academic impact, for papers by Mark L. Graham Breakdown of academic impact, for papers by A. Rubagotti Breakdown of academic impact, for papers by Masashi Takano Breakdown of academic impact, for papers by R.I. Nicholson Breakdown of academic impact, for papers by R A McClelland
Rankless by CCL
2026